Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity

Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943 · cited 1×

Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20

Reff, M., Carner, K., Chambers, K., Chinn, P., Leonard, J., Raab, R., Newman, R., Hanna, N., & Anderson, D. (1994) · Blood · doi:10.1182/blood.v83.2.435.435 · Cited by 1,996

Biosynthetic controls that determine the branching and microheterogeneity of protein-bound oligosaccharides

Schachter, H. (1986) · Biochemistry and Cell Biology · doi:10.1139/o86-026 · Cited by 526

Biosynthetic Controls That Determine the Branching and Microheterogeneity of Protein-Bound Oligosaccharides

Schachter, H. (1986) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-5209-9_2 · Cited by 510

Sequencing of N-Linked Oligosaccharides Directly from Protein Gels: In-Gel Deglycosylation Followed by Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry and Normal-Phase High-Performance Liquid Chromatography

Küster, B., Wheeler, S. F., Hunter, A. P., Dwek, R. A., & Harvey, D. J. (1997) · Analytical Biochemistry · doi:10.1006/abio.1997.2199 · Cited by 358

Effect of glycosylation on antibody function: implications for genetic engineering

Wright, A. M., & Morrison, S. L. (1997) · Trends in biotechnology · doi:10.1016/s0167-7799(96)10062-7 · Cited by 317

Quantitative aspects of the matrix‐assisted laser desorption mass spectrometry of complex oligosaccharides

Harvey, D. J. (1993) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.1290070712 · Cited by 265

In Pursuit of the Optimal Fed‐Batch Process for Monoclonal Antibody Production

Bibila, T. A., & Robinson, D. K. (1995) · Biotechnology Progress · doi:10.1021/bp00031a001 · Cited by 251

Overlapping distribution of two glycosyltransferases in the Golgi apparatus of HeLa cells.

Nilsson, T., Pypaert, M., Hoe, M. H., Slusarewicz, P., Berger, E. G., & Warren, W. G. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.120.1.5 · Cited by 222

Multiple interactions of IgG with its core oligosaccharide can modulate recognition by complement and human Fc γ receptor I and influence the synthesis of its oligosaccharide chains

Lund, J., Takahashi, N., Pound, J. D., Goodall, M. D., & Jefferis, R. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.11.4963 · Cited by 216

Clinical significance of IgG Fc receptors and FcγR-directed immunotherapies

Deo, Y. M., Graziano, R. F., Repp, R., & van de Winkel, J. G. J. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01007-4 · Cited by 213

Purification, cDNA cloning, and expression of UDP-N-acetylglucosamine: beta-D-mannoside beta-1,4N-acetylglucosaminyltransferase III from rat kidney.

Nishikawa, A., Ihara, Y., Hatakeyama, M., Kangawa, K., & Taniguchi, N. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37172-8 · Cited by 195

Variations in Oligosaccharide−Protein Interactions in Immunoglobulin G Determine the Site-Specific Glycosylation Profiles and Modulate the Dynamic Motion of the Fc Oligosaccharides

Wormald, M. R., Rudd, P. M., Harvey, D. J., Chang, S.-C., Scragg, I. G., & Dwek, R. A. (1997) · Biochemistry · doi:10.1021/bi9621472 · Cited by 191

Glycosylation and biological activity of CAMPATH-1H expressed in different cell lines and grown under different culture conditions.

Lifely, M. R., Hale, C., Boyce, S., Keen, M., & Phillips, J. (1995) · Glycobiology · doi:10.1093/glycob/5.8.813 · Cited by 173

Measurement of cytotoxicity by target cell release and retention of the fluorescent dye bis-carboxyethyl-carboxyfluorescein (BCECF)

Kolber, M. A., Quinones, R., Gress, R. E., & Henkert, P. A. (1988) · Journal of Immunological Methods · doi:10.1016/0022-1759(88)90427-9 · Cited by 132

Production of monoclonal antibodies in COS and CHO cells

Trill, J. J., Shatzman, A. R., & Subinay, G. (1995) · Current Opinion in Biotechnology · doi:10.1016/0958-1669(95)80092-1 · Cited by 118

A dominant mutation to ricin resistance in Chinese hamster ovary cells induces UDP-GlcNAc:glycopeptide beta-4-N-acetylglucosaminyltransferase III activity.

Campbell, C. E., & Stanley, P. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)90704-0 · Cited by 100

Effect of Structure on the Signal Strength of Oligosaccharides in Matrix-assisted Laser Desorption/Ionization Mass Spectrometry on Time-of-flight and Magnetic Sector Instruments

Naven, T. J. P., & Harvey, D. J. (1996) · Rapid Communications in Mass Spectrometry · doi:10.1002/(sici)1097-0231(199608)10:11 · Cited by 90

Anti-Renal-Cell Carcinoma Chimeric Antibody G250 Facilitates Antibody-Dependent Cellular Cytotoxicity with In Vitro and In Vivo Interleukin-2-Activated Effectors

Surfus, J. E., Hank, J. A., Oosterwijk, E., Welt, S., Lindstrom, M. J., Albertini, M. R., Schiller, J. H., & Sondel, P. M. (1996) · Journal of Immunotherapy · doi:10.1097/00002371-199605000-00003 · Cited by 74

Structural Characterization of the N-Glycans of a Humanized Anti-CD18 Murine Immunoglobulin G

Ip, C. C. Y., Miller, W. J. W., Silberklang, M., Mark, G. E., Ellis, R. W., Huang, L., Glushka, J., Vanhalbeek, H., Zhu, J., & Alhadeff, J. A. (1994) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1994.1055 · Cited by 37

General applications of PCR to gene cloning and manipulation

Clackson, T., Güssow, D., & Jones, P. T. (1991) · doi:10.1093/oso/9780199631964.003.0012 · Cited by 36

Tumor specific Epstein-Barr virus infection is not associated with leiomyosarcoma in human immunodeficiency virus negative individuals

Hill, M. A., Araya, J. C., Eckert, M. W., Gillespie, A. T., Hunt, J. D., & Levine, E. A. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970715)80:2 · Cited by 29

Magic Bullets at Last! Finally—Approval of a Monoclonal Antibody for the Treatment of Cancer!!!

Dillman, R. O. (1997) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.1997.12.223 · Cited by 28

The Use of High-Performance Anion-Exchange Chromatography and Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry to Monitor and Identify Oligosaccharide Degradation

Field, M., Papac, D. I., & Jones, A. (1996) · Analytical Biochemistry · doi:10.1006/abio.1996.0295 · Cited by 27

Production and characterization of a mouse/human chimeric antibody directed against human neuroblastoma

Amstutz, H., Rytz, C., Novak‐Hofer, I., Spycher, M. O., Schubiger, P. A., Blaser, K., & Morgenthaler, J. ‐. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910530127 · Cited by 23

Variation in N-linked carbohydrate chains in different batches of two chimeric monoclonal IgG1 antibodies produced by different murine SP2/0 transfectoma cell subclones

Bergwerff, A. A., Stroop, C. J. M., Murray, B. J., Holtorf, A., Pluschke, G., van Oostrum, J., Kamerling, J. P., & Vliegenthart, J. F. G. (1995) · Glycoconjugate Journal · doi:10.1007/bf00731335 · Cited by 23

Production of recombinant protein therapeutics in cultivated mammalian cells

Wurm, F. M. (2004) · Nature Biotechnology · doi:10.1038/nbt1026 · Cited by 2,032

Lack of Fucose on Human IgG1 N-Linked Oligosaccharide Improves Binding to Human FcγRIII and Antibody-dependent Cellular Toxicity

Shields, R. L., Lai, J., Keck, R., O'Connell, L. Y., Hong, K., Meng, Y. G., Weikert, S. H. A., & Presta, L. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202069200 · Cited by 1,835

The Absence of Fucose but Not the Presence of Galactose or Bisecting N-Acetylglucosamine of Human IgG1 Complex-type Oligosaccharides Shows the Critical Role of Enhancing Antibody-dependent Cellular Cytotoxicity

Shinkawa, T., Nakamura, K., Yamane, N., Shoji-Hosaka, E., Kanda, Y., Sakurada, M., Uchida, K., Anazawa, H., Satoh, M., Yamasaki, M., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210665200 · Cited by 1,413

Global view of human protein glycosylation pathways and functions

Schjoldager, K. T.-B. G., Narimatsu, Y., Joshi, H. J., & Clausen, H. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00294-x · Cited by 1,353

The Impact of Glycosylation on the Biological Function and Structure of Human Immunoglobulins

Arnold, J. N., Wormald, M. R., Sim, R. B., Rudd, P. M., & Dwek, R. A. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141702 · Cited by 1,354

Influence of Variable N-Glycosylation on the Cytolytic Potential of Chimeric CD19 Antibodies

Barbin, K., Stieglmaier, J., Saul, D., Stieglmaier, K., Stockmeyer, B., Pfeiffer, M. M., Lang, P., & Fey, G. H. (2006) · Journal of Immunotherapy · doi:10.1097/01.cji.0000175684.28615.7b · Cited by 28

Expression of GnTIII in a recombinant anti‐CD20 CHO production cell line: Expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FCγRIII

Davies, J., Jiang, L., Pan, L., LaBarre, M. J., Anderson, D., & Reff, M. (2001) · Biotechnology and Bioengineering · doi:10.1002/bit.1119 · Cited by 327

Modulation of therapeutic antibody effector functions by glycosylation engineering: Influence of Golgi enzyme localization domain and co‐expression of heterologous β1, 4‐N‐acetylglucosaminyltransferase III and Golgi α‐mannosidase II

Ferrara, C., Brünker, P., Suter, T., Moser, S., Püntener, U., & Umaña, P. (2006) · Biotechnology and Bioengineering · doi:10.1002/bit.20777 · Cited by 305

Improved Effector Functions of a Therapeutic Monoclonal Lewis Y-Specific Antibody by Glycoform Engineering

Schuster, M., Umaña, P., Ferrara, C., Brünker, P., Gerdes, C. A., Waxenecker, G., Wiederkum, S., Schwager, C., Loibner, H., Himmler, G., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4212 · Cited by 91

Engineering of protein glycosylation in Chinese hamster ovary cells

Umaña, P. (2005) · CaltechTHESIS (California Institute of Technology) · doi:10.7907/6ceh-kt92 · Cited by 1